Keryx Biopharmaceuticals, Inc.


One Marina Park Drive, 12th Floor
Boston, MA   02210

Keryx Biopharmaceuticals, Inc. is a commercial stage company focused on bringing innovative medicines to people with renal disease and their healthcare providers. In September 2014, the U.S. Food and Drug Administration approved Keryx’s first medicine. The company is headquartered in Boston, MA with approximately 190 full-time employees across Boston and its field-based teams. For more information about the company, please visit